Albisetti, M., Schlosser, A., Brueckmann, M., Gropper, S., Glund, S., Tartakovsky, I., . . . Reilly, P. A. (2017). Rationale and design of a phase III safety trial of idarucizumab in children receiving dabigatran etexilate for venous thromboembolism. Res Pract Thromb Haemost.
Citación estilo ChicagoAlbisetti, Manuela, Arno Schlosser, Martina Brueckmann, Savion Gropper, Stephan Glund, Igor Tartakovsky, Leonardo R. Brandão, and Paul A. Reilly. "Rationale and Design of a Phase III Safety Trial of Idarucizumab in Children Receiving Dabigatran Etexilate for Venous Thromboembolism." Res Pract Thromb Haemost 2017.
Cita MLAAlbisetti, Manuela, et al. "Rationale and Design of a Phase III Safety Trial of Idarucizumab in Children Receiving Dabigatran Etexilate for Venous Thromboembolism." Res Pract Thromb Haemost 2017.